Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib
- 26 November 2005
- journal article
- letter
- Published by Springer Nature in Annals of Hematology
- Vol. 85 (2), 132-133
- https://doi.org/10.1007/s00277-005-0027-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Bortezomib is an efficient agent in plasma cell leukemiasInternational Journal of Cancer, 2004
- A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaBritish Journal of Haematology, 2004
- A Phase 2 Study of Bortezomib in Relapsed, Refractory MyelomaNew England Journal of Medicine, 2003
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Plasma cell leukemia. Report on 17 casesArchives of Internal Medicine, 1974